Literature DB >> 16297528

Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.

Jean S Fleming1, Clare R Beaugié, Izhak Haviv, Georgia Chenevix-Trench, Olivia L Tan.   

Abstract

Epithelial ovarian cancer (EOC) is often a lethal disease because in many cases early symptoms go undetected. Although research proceeds apace, as yet there are few reliable and specific biomarkers for the early stages of the disease. EOC is an umbrella label for a highly heterogeneous collection of cancers, which includes tumours of low malignant potential, serous cystadenomas, mucinous and clear cell carcinomas, all of which are likely to arise from a number of epithelial cell types and a variety of progenitor lesions. Many, but not all types of EOC are thought to arise from the cells lining ovarian inclusion cysts. In this review, we discuss the hypotheses that have driven our ideas on epithelial ovarian carcinogenesis and examine the morphological and genetic evidence for pathways to EOC. The emergence of laser-capture microdissection and expression profiling by microarray technologies offers the promise of defining these pathways more accurately, as well as providing us with the tools for earlier diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297528     DOI: 10.1016/j.mce.2005.09.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  76 in total

Review 1.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Qiliu Peng; Shan Ren; Xianjun Lao; Yu Lu; Xiaolian Zhang; Zhiping Chen; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-07-16

3.  The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer.

Authors:  Yoshihiro Minamiya; Masatomo Miura; Yudai Hinai; Hajime Saito; Manabu Ito; Kazuhiro Imai; Takashi Ono; Satoru Motoyama; Jun-ichi Ogawa
Journal:  Tumour Biol       Date:  2010-08-05

4.  Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract.

Authors:  Jean S Fleming; H James McQuillan; Melanie J Millier; Grant C Sellar
Journal:  Reproduction       Date:  2009-01-27       Impact factor: 3.906

5.  Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.

Authors:  H R Harris; L J Titus; D W Cramer; K L Terry
Journal:  Int J Cancer       Date:  2016-10-06       Impact factor: 7.396

6.  Reproductive factors and ovarian cancer risk in African-American women.

Authors:  Patricia G Moorman; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Frances Wang; Joellen M Schildkraut
Journal:  Ann Epidemiol       Date:  2016-07-18       Impact factor: 3.797

Review 7.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

8.  Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.

Authors:  Mollie E Barnard; Elizabeth M Poole; Gary C Curhan; A Heather Eliassen; Bernard A Rosner; Kathryn L Terry; Shelley S Tworoger
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

9.  Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Authors:  Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen
Journal:  Am J Epidemiol       Date:  2016-04-15       Impact factor: 4.897

10.  Ovarian cancer and DNA repair: DNA ligase IV as a potential key.

Authors:  Joana Assis; Deolinda Pereira; Rui Medeiros
Journal:  World J Clin Oncol       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.